Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-24

Clinical Trial Update: The Effect of Antiviral Therapy With Pegylated Interferon-alpha on Auditory Disability

View source ↗

Summary

A completed clinical trial evaluated the effect of pegylated interferon-alpha antiviral therapy on auditory disability, including sudden sensorineural hearing l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pegylated interferon alpha (Pegylated interferon alfa)

Snippet

Sponsor: Carmel Medical Center | Conditions: Hearing Loss, Sudden Deafness | Status: COMPLETED